Bristol Myers (BMY) revenue was $48.2B in FY2025 (-0% YoY). The tables below show the complete quarterly and annual revenue history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Revenue
Fiscal Year
Revenue
YoY
2025
$48.2B
-0%
2024
$48.3B
+7%
2023
$45.0B
-2%
2022
$46.2B
-0%
2021
$46.4B
+9%
2020
$42.5B
+63%
2019
$26.1B
+16%
2018
$22.6B
+9%
2017
$20.8B
+7%
2016
$19.4B
+17%
2015
$16.6B
+4%
2014
$15.9B
-3%
2013
$16.4B
-7%
2012
$17.6B
-17%
2011
$21.2B
+9%
2010
$19.5B
+4%
2009
$18.8B
+6%
2008
$17.7B
+13%
2007
$15.6B
Recent Quarterly Revenue
Quarter
Revenue
Q2 2026
$13.0B
Q1 2026
$11.5B
Q4 2025
$12.5B
Q3 2025
$12.2B
Q2 2025
$12.3B
Q1 2025
$11.2B
Q4 2024
$12.3B
Q3 2024
$11.9B
Q2 2024
$12.2B
Q1 2024
$11.9B
Q4 2023
$11.5B
Q3 2023
$11.0B
Source: BMY on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.